- Home
- EBMT vs ATOS Comparison
EBMT vs ATOS Comparison
Compare EBMT & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBMT
- ATOS
- Stock Information
- Founded
- EBMT 1922
- ATOS 2009
- Country
- EBMT United States
- ATOS United States
- Employees
- EBMT N/A
- ATOS N/A
- Industry
- EBMT Major Banks
- ATOS Biotechnology: Pharmaceutical Preparations
- Sector
- EBMT Finance
- ATOS Health Care
- Exchange
- EBMT Nasdaq
- ATOS Nasdaq
- Market Cap
- EBMT 127.9M
- ATOS 107.2M
- IPO Year
- EBMT N/A
- ATOS 2012
- Fundamental
- Price
- EBMT $16.46
- ATOS $0.84
- Analyst Decision
- EBMT
- ATOS Strong Buy
- Analyst Count
- EBMT 0
- ATOS 3
- Target Price
- EBMT N/A
- ATOS $6.17
- AVG Volume (30 Days)
- EBMT 92.7K
- ATOS 1.5M
- Earning Date
- EBMT 08-05-2025
- ATOS 08-11-2025
- Dividend Yield
- EBMT 3.51%
- ATOS N/A
- EPS Growth
- EBMT 26.99
- ATOS N/A
- EPS
- EBMT 1.41
- ATOS N/A
- Revenue
- EBMT $82,271,000.00
- ATOS N/A
- Revenue This Year
- EBMT N/A
- ATOS N/A
- Revenue Next Year
- EBMT $5.11
- ATOS N/A
- P/E Ratio
- EBMT $11.53
- ATOS N/A
- Revenue Growth
- EBMT 0.06
- ATOS N/A
- 52 Week Low
- EBMT $12.61
- ATOS $0.55
- 52 Week High
- EBMT $18.49
- ATOS $1.66
- Technical
- Relative Strength Index (RSI)
- EBMT 41.75
- ATOS 45.75
- Support Level
- EBMT $15.96
- ATOS $0.84
- Resistance Level
- EBMT $17.31
- ATOS $0.93
- Average True Range (ATR)
- EBMT 0.42
- ATOS 0.05
- MACD
- EBMT -0.10
- ATOS -0.00
- Stochastic Oscillator
- EBMT 28.74
- ATOS 18.69
About EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.